The only credible bull thesis is turnaround optionality combined with sector leverage. Institutional ownership at $7.67 suggests some level of professional participation, and a current ratio of 2 indicates short-term liquidity is not immediately broken. If EPS improves from -5.2 to -$1.17 as estimated, that magnitude of improvement could dramatically re-rate sentiment, especially in a Healthcare technology niche that can scale rapidly once fixed costs are absorbed. For aggressive GARP investors, the valuation at $336M market cap may represent a call option on operational inflection, particularly if operating leverage begins to close the -167.60% margin gap.